Cetera Investment Advisers
MDGL icon

Cetera Investment Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Cetera Investment Advisers’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
2,696
-261
-9% -$134K ﹤0.01% 2680
2026
Q1 		$1.55M Sell
2,957
-984
-25% -$470K ﹤0.01% 2511
2025
Q4 		$2.3M Buy
3,941
+215
+6% +$110K ﹤0.01% 2091
2025
Q3 		$1.71M Buy
3,726
+1,866
+100% +$696K ﹤0.01% 2317
2025
Q2 		$563K Sell
1,860
-972
-34% -$290K ﹤0.01% 2865
2025
Q1 		$938K Sell
2,832
-50
-2% -$16.4K ﹤0.01% 2313
2024
Q4 		$889K Buy
2,882
+1,328
+85% +$374K ﹤0.01% 2244
2024
Q3 		$330K Buy
1,554
+14
+0.9% +$3.58K ﹤0.01% 2981
2024
Q2 		$431K Sell
1,540
-713
-32% -$170K ﹤0.01% 2704
2024
Q1 		$602K Buy
+2,253
New +$531K ﹤0.01% 2464

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cetera Investment Advisers's MDGL Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Madrigal Pharmaceuticals (MDGL) stake by 8.8% in Q2 2026, selling an estimated $134K and leaving 2,696 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

Cetera Investment Advisers first reported a position in MDGL in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.3M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Cetera Investment Advisers held 2,696 shares of Madrigal Pharmaceuticals worth $1.45M as of Q2 2026.
  • Cetera Investment Advisers sold 261 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $134K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2680 holding.
  • Cetera Investment Advisers first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Madrigal Pharmaceuticals position peaked at $2.3M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.